FOXA1 not only inhibits the molecular phenotype of basal breast cancer cells but also activates the transcription of E-calmodulin and p1Kip51 to block EMT and cell proliferation in basal breast cancer [112–114]. Here, FOXA1 is linked to breast carcinoma.